Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients

BACKGROUND: We previously reported an HLA-A24-restricted cytotoxic T-cell epitope, Survivin-2B80-88, derived from a splice variant of survivin, survivin-2B. In this report, we show a novel HLA-A24-restricted T-cell epitope, Survivin-C58, derived from a wild type survivin, and compared their immunoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Jun-ichi, Torigoe, Toshihiko, Hirohashi, Yoshihiko, Idenoue, Satomi, Miyazaki, Akihiro, Yamaguchi, Akira, Hiratsuka, Hiroyoshi, Sato, Noriyuki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627828/
https://www.ncbi.nlm.nih.gov/pubmed/19123955
http://dx.doi.org/10.1186/1479-5876-7-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627828/
https://www.ncbi.nlm.nih.gov/pubmed/19123955
http://dx.doi.org/10.1186/1479-5876-7-1

Ejemplares similares